| History of a gene patent: tracing the development and application of commercial BRCA testing B Williams-Jones Health Law Journal 10, 121-144, 2002 | 160 | 2002 |
| Actor-network theory: a tool to support ethical analysis of commercial genetic testing B Williams-Jones, JE Graham New genetics and society 22 (3), 271-296, 2003 | 159 | 2003 |
| Shifting emphasis from pharmacogenomics to theragnostics V Ozdemir, B Williams-Jones, SJ Glatt, MT Tsuang, JB Lohr, C Reist Nature Biotechnology 24 (8), 942-946, 2006 | 138 | 2006 |
| Mapping the integration of social and ethical issues in health technology assessment P Lehoux, B Williams-Jones International Journal of Technology Assessment in Health Care 23 (1), 9-16, 2007 | 135 | 2007 |
| How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs P Lehoux, G Daudelin, B Williams-Jones, JL Denis, C Longo Research Policy 43 (6), 1025-1038, 2014 | 130 | 2014 |
| Where there’s a web, there’s a way: commercial genetic testing and the internet B Williams-Jones Public Health Genomics 6 (1), 46-57, 2003 | 87 | 2003 |
| Authorship and responsibility in health sciences research: a review of procedures for fairly allocating authorship in multi-author studies E Smith, B Williams-Jones Science and Engineering Ethics 18 (2), 199-212, 2012 | 79 | 2012 |
| What leads to better health care innovation? Arguments for an integrated policy-oriented research agenda P Lehoux, B Williams-Jones, F Miller, D Urbach, S Tailliez Journal of health services research & policy 13 (4), 251-254, 2008 | 72 | 2008 |
| Rhetoric and Hype: Where's the 'Ethics' in Pharmacogenomics? B Williams-Jones, OP Corrigan American Journal of Pharmacogenomics 3 (6), 375-383, 2003 | 72 | 2003 |
| ‘Be ready against cancer, now’: direct-to-consumer advertising for genetic testing B Williams-Jones New Genetics and Society 25 (01), 89-107, 2006 | 60 | 2006 |
| Reproductive tourism in Argentina: clinic accreditation and its implications for consumers, health professionals and policy makers E Smith, J Behrmann, C Martin, B Williams-Jones Developing World Bioethics 10 (2), 59-69, 2010 | 55 | 2010 |
| What place for ethics? An overview of ethics teaching in occupational therapy and physiotherapy programs in Canada A Hudon, M Laliberté, M Hunt, V Sonier, B Williams-Jones, B Mazer, ... Disability & Rehabilitation 36 (9), 775-780, 2014 | 54 | 2014 |
| Global bioethics–myth or reality? S Holm, B Williams-Jones BMC Medical Ethics 7 (1), 1-10, 2006 | 50 | 2006 |
| Epigenetics and the environment in bioethics C Dupras, V Ravitsky, B Williams-Jones Bioethics 28 (7), 327-334, 2014 | 48 | 2014 |
| Mapping translational research in personalized therapeutics: from molecular markers to health policy V Ozdemir, B Williams-Jones, DM Cooper, T Someya, B Godard Future Medicine Ltd 8 (2), 177-185, 2007 | 45 | 2007 |
| The worlds and modalities of engagement of design participants: A qualitative case study of three medical innovations P Lehoux, M Hivon, B Williams-Jones, D Urbach Design Studies 32 (4), 313-332, 2011 | 41 | 2011 |
| Ethics and genetics: Susceptibility testing in the workplace C MacDonald, B Williams-Jones Journal of Business Ethics 35 (3), 235-241, 2002 | 39 | 2002 |
| Providing genetic testing through the private sector: a view from Canada T Caulfield, MM Burgess, B Williams-Jones ISUMA: Canadian Journal of Policy Research 2 (3), 72-81, 2001 | 39 | 2001 |
| Pharmacogenetics: the bioethical problem of DNA investment banking OP Corrigan, B Williams-Jones Studies in History and Philosophy of Science Part C: Studies in History and …, 2006 | 38 | 2006 |
| Personalized medicine, bioethics and social responsibilities: Re-thinking the pharmaceutical industry to remedy inequities in patient care and international health C Olivier, B Williams-Jones, B Godard, B Mikalson, V Ozdemir Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2008 | 34 | 2008 |
Pascale LehouxProfesseur, Université de MontréalVerified email at umontreal.ca
